Search Results 521-530 of 13947 for Moderate acute malnutrition
... acutely to MCF with mild COVID-19 and patients presenting with severe COVID-19. This will be accomplished by utilizing the the immunoSEQ Human T-cell ...
Acute infections within 14 days prior to first dose of study drug requiring ... Subject must not have used systemic strong or moderate inhibitor or ...
Science of Healthcare Delivery PAG. Exclusion Criteria: Patients. Major barriers to providing informed consent (i.e. dementia, severe hearing or visual ...
The purpose of this study of sulfasalazine is to see how well it works in preventing acute diarrhea in patients with cancer who are undergoing pelvic radiation ...
Learn about this cancer that forms in the blood and bone marrow. Treatments include medicines and bone marrow transplant, also called stem cell transplant.
Subject has severe and heterogeneous emphysema with severe dyspnea; Subject certified to meet the criteria of ATS/ERS guidelines for management of stable ...
... acute coronary syndrome (ACS) diagnosed with either ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction ...
The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy. Participation ...
The objective of this study is to evaluate the feasibility of alternative Net Ultrafiltration (UFNET) rate strategies among critically ill adults with acute ...
Subject requires high level chronic immunomodulatory therapy to treat a moderate to severe chronic inflammatory autoimmune disorder. Subject is on an ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.